Fraud, errors taint a key study of widely used Sanofi drug; despite some faked results, FDA approves antibiotic; one doctor's cocaine use; company defends safety
- PMID: 16838449
Item in Clipboard
Fraud, errors taint a key study of widely used Sanofi drug; despite some faked results, FDA approves antibiotic; one doctor's cocaine use; company defends safety
Wall St J (East Ed).
.
No abstract available
Similar articles
-
The FDA and the case of Ketek.N Engl J Med. 2007 Apr 19;356(16):1601-4. doi: 10.1056/NEJMp078032. N Engl J Med. 2007. PMID: 17442902 No abstract available.
-
Ketek--the FDA perspective.N Engl J Med. 2007 Apr 19;356(16):1675-6. doi: 10.1056/NEJMc076135. N Engl J Med. 2007. PMID: 17442912 No abstract available.
-
A fine pile of paté: the cautionary tale of telithromycin, hepatic failure, and study 3014.Surg Infect (Larchmt). 2006 Jun;7(3):247-9. doi: 10.1089/sur.2006.7.247. Surg Infect (Larchmt). 2006. PMID: 16875457 No abstract available.
-
Understanding the regulatory hurdles for antibacterial drug development in the post-Ketek world.Ann N Y Acad Sci. 2011 Dec;1241:153-61. doi: 10.1111/j.1749-6632.2011.06300.x. Ann N Y Acad Sci. 2011. PMID: 22191531 Review.
-
Integrity of scientific data: transparency of clinical trial data.Therapie. 2007 May-Jun;62(3):203-9, 211-6. doi: 10.2515/therapie:2007043. Epub 2007 Sep 6. Therapie. 2007. PMID: 17803887 Review. English, French.
Cited by
-
The power of the case report.J Med Toxicol. 2006 Dec;2(4):139-40. doi: 10.1007/BF03161180. J Med Toxicol. 2006. PMID: 18072132 Free PMC article. No abstract available.
-
Recent Advances in the Rational Design and Optimization of Antibacterial Agents.Medchemcomm. 2016 Sep 1;7(9):1694-1715. doi: 10.1039/C6MD00232C. Epub 2016 Jul 7. Medchemcomm. 2016. PMID: 27642504 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical